Product Information
VIMPAT 10 MG/ML SOLUTION is a brand product labeled by UCB, Inc., priced at $2.2976 per ML under NDC 00131541072. Its NADAC has been published 313 times since Aug 26, 2020.
FDA first approved this application on Apr 20, 2010. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the lacosamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/mL
Manufacturer
UCB, Inc.NDC
00131541072
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LACOSAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA022255FDA Approved
4/20/2010
TE Code
AA
On Market Since
4/20/2010
Pharmacological Classes
Price Statistics
The NADAC for VIMPAT 10 MG/ML SOLUTION has been published 313 times since Aug 26, 2020, and over the history we have for it it has risen 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2976 per ML |
|---|---|
| All-time high | $2.2997 (May 13, 2026) |
| All-time low | $1.7620 (Aug 26, 2020) |
| 52-week high | $2.2997 |
| 52-week low | $2.2414 |
| Median price | $2.1003 |
| Average price | $2.0773 |
| Largest weekly change | +6.9% (Jan 12, 2022) |
| Weeks tracked | 313 |
| Tracking since | Aug 26, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lacosamide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VIMPAT 10 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for VIMPAT 10 MG/ML SOLUTION, manufactured by UCB, Inc., is $2.2976 per ML (NDC 00131541072), effective Aug 19, 2026.
How has the price of VIMPAT 10 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for VIMPAT 10 MG/ML SOLUTION has risen 30.4%. It has been tracked across 313 weekly CMS publications since Aug 26, 2020.
What are the highest and lowest recorded NADAC prices for VIMPAT 10 MG/ML SOLUTION?
Since Aug 26, 2020, the NADAC for VIMPAT 10 MG/ML SOLUTION has ranged from a low of $1.7620 (Aug 26, 2020) to a high of $2.2997 (May 13, 2026), with a median of $2.1003 per ML.
Are there cheaper alternatives to VIMPAT 10 MG/ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of VIMPAT 10 MG/ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VIMPAT 10 MG/ML SOLUTION?
VIMPAT 10 MG/ML SOLUTION (NDC 00131541072) is labeled by UCB, Inc., and CMS classifies it as a brand product.